ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
125 hedge funds and large institutions have $480M invested in Achillion Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
-4
Holders Change %
-3.1%
% of All Funds
3.12%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.1%
New
14
Increased
41
Reduced
41
Closed
17
Calls
$1.89M
Puts
$1.16M
Net Calls
+$731K
Net Calls Change
+$596K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$28.1M |
| 2 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$9.59M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.32M |
| 4 |
AC
Armistice Capital
New York
|
+$4.58M |
| 5 |
AG
Artal Group
Luxembourg
|
+$4.49M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$16M |
| 2 |
Millennium Management
New York
|
-$11.7M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$4.97M |
| 4 |
Goldman Sachs
New York
|
-$4.07M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.41M |
